Answers are grounded in this paper and cite their sources.
To the Editors: Common causes for neonatal lung masses include developmental abnormalities like pulmonary sequestration, congenital pulmonary airway malformation, bronchogenic cyst, and primary lung tumors. Fungal pneumonia mimicking a radiologic appearance of a malignant lung mass is uncommon in neonates. We report a neonate who presented with a lung mass and was finally diagnosed to have pulmonary aspergillosis with an underlying chronic granulomatous disease (CGD). A full-term 3-kg male child, born by normal delivery to a third-degree consanguineously married couple, was symptomatic since day 12 of life when he started with fever, cough, fast breathing, and poor feeding. Chest radiograph revealed a large homogenous opacity in the right upper lung zone (Fig. 1A). He was initially managed as a case of pneumonia and late-onset sepsis with intravenous (IV) meropenem. He was referred to our tertiary care center as he showed no signs of improvement even after 5 days of IV antibiotics. Clinical differential diagnoses considered were pneumonia due to a multidrug-resistant pathogen, tuberculosis, and airway malformations. However, multiple blood cultures were sterile. Contrast-enhanced computed tomography of the chest showed multiple nodules of varying sizes in both lungs with underlying necrosis (Fig. 1B). Differential diagnoses considered based on radiology were pleuropulmonary blastoma with metastatic nodules and invasive fungal infection. Clinical condition deteriorated, and he required mechanical ventilation from day 20 of illness. We initiated IV liposomal amphotericin B—5 mg/kg/d empirically. Bacterial cultures of tracheal aspirate did not grow any organisms. Ultrasound-guided fine-needle aspiration of right lung lesion revealed inflammatory cells and fungal elements suggestive of Aspergillus sp. (Fig. 1C). The antifungal agent was later changed to IV voriconazole (6 mg/kg/d twice daily on the first day, followed by 4 mg/kg/d subsequently) that was continued for next 1 week. However, he succumbed to respiratory failure at day 29 of illness.FIGURE 1.: A, Chest radiograph anteroposterior view showing a large homogenous opacity in right upper lung zone and a smaller nodular opacity visualized in the right lower lung zone; B, CECT of the chest (lung window) showing multiple nodules of varying sizes seen in bilateral lungs with the largest nodule in right upper lobe having mediastinal extension; C, CECT Chest (mediastinal window) showing the corresponding areas with central hypodensity suggestive of necrosis; D, FNAC smears from lesion in right lung show the presence of acute inflammatory infiltrate, occasional giant cells, benign respiratory epithelial cell clusters, and degenerated cells; E, PAS stain highlights fungal profiles, which are slender septate with acute angle branching conforming to the morphology of aspergillus. CECT indicates contrast-enhanced computed tomography; FNAC, fine needle aspiration cytology; PAS, periodic acid-Schiff.Because of invasive pulmonary aspergillosis in a term, healthy neonate without any significant risk factors like extreme prematurity, central lines, multiple antimicrobials, or multiple invasive procedures, an underlying primary immunodeficiency disease was considered. Hemogram showed leukocyte count 10.6 × 109/L (neutrophils, 5.3 × 109/L; lymphocytes, 2.9 × 109/L; monocytes, 2.1 × 109/L; eosinophils, 0.36 × 109/L), hemoglobin 9.7 g/dL, and platelet count 229 × 109/L. Peripheral smear showed leukocyte shift to the left with toxic granules. Nitro-blue tetrazolium test showed no reduction of dye in the stimulated neutrophils of the patient. Flow cytometry-based dihydrorhodamine assay revealed a low stimulation index consistent with CGD (see Figure, Supplemental Digital Content 1, https://links.lww.com/INF/E174). Dihydrorhodamine assay of the mother did not show mosaic peak to suggest an X-linked carrier of CGD. A next-generation sequencing (44 gene primary immunodeficiency disease panel) did not reveal pathogenic variants in CYBB (cytochrome B-245 β chain), CYBA (cytochrome B-245 α chain), or NCF2 (neutrophil cytosolic factor-2). Sanger sequencing of NCF1 (neutrophil cytosolic factor-1) revealed a pathogenic homozygous variant c.73_74delGT, p.Tyr26HisfsX25. Our case had a neonatal presentation of autosomal recessive CGD due to NCF1 defect with fungal pneumonia (Aspergillus sp.). The radiologic appearance of invasive pulmonary aspergillosis can resemble a malignant lung mass; however, reports are scarce in the neonatal age group.1 Moreover, neonatal presentation of CGD is uncommon, and there are only a handful of reports with molecular confirmation of diagnosis.2,3 Clinical manifestations of X-linked CGD are severe and present at an earlier age compared with autosomal recessive form. Herman et al2 reported neonatal CGD with pulmonary aspergillosis and liver abscess due to Serratia sp.; however, the molecular defect was not mentioned. Saito et al3 reported a neonate with CGD and invasive aspergillosis due to NCF2 defect. Patients with NCF1 defect usually present at a later age and tend to have a better prognosis compared with X-linked CGD.4,5 To the best of our knowledge, neonatal presentation of CGD due to NCF1 defect has not previously been reported. To conclude, CGD must be suspected in neonates presenting with invasive pulmonary fungal infection in the absence of any risk factors. Establishment of genetic diagnosis can aid in prenatal diagnosis of the affected families. ACKNOWLEDGMENTS None.
No takes yet. Share an insight, caveat, or question.
Arul et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: